News and Events

Foundation News:

Barbara J. O’Shaughnessy: A Woman of Grace and Giving 

A long-time friend of Midland Memorial Foundation, Barbara J. O’Shaughnessy, died on September 20, 2014, at the age of 92.  Barbara was born July 5, 1922 in Austin, Minnesota, and graduated from the University of Minnesota in 1944.  She married Donald E. O’Shaughnessy in 1946, and moved to Midland, Texas in 1950.

Barbara and her family have a long history with Midland Memorial Hospital.  Five of her six children were born at MMH.  In 1956, Barbara’s husband, Donald E. O’Shaughnessy was elected to the Board of Trustees for a term from 1956 through 1960.  In 1981 Don joined the Board of Governors where he served until his death in late 1995.  Barbara joined the Midland Memorial Foundation Board of Governors in 1999 and joined the distinguished Governors Emeriti in 2010.  She was faithfully committed to her leadership role at Midland Memorial Foundation.

In 1956, Barbara and Don began their philanthropic history with MMH by helping to purchase the very latest in radiology equipment. Through the years, they have provided gifts for nursing scholarships as well as financial assistance for cancer patients. Barbara contributed to the building efforts of the Craddick Medical Office Building and most recently contributed to the establishment of the Scharbauer Tower project. Not only did Barbara and Don give personal monetary gifts, they also assisted in securing contributions from the I.A. O’Shaughnessy Foundation for MMH’s first magnetic resonance imaging equipment (MRI), MMF’s Endowment Fund, the Craddick Medical Office Building and the Scharbauer Tower. In 2009, Barbara’s children and the O’Shaughnessy Foundation also made possible the Barbara O’Shaughnessy Garden at MMH. The garden, located adjacent to The Market at MMH, was dedicated to Barbara in the summer of 2010 with several generations of her family members and many of her friends looking on proudly.    

In 2010, the O’Shaughnessy children established the Barbara J. O’Shaughnessy Endowment Fund at Midland Memorial Foundation, in honor of their mother.  This surprise Christmas gift was the perfect culmination of a lifetime of philanthropic devotion to Midland Memorial Hospital and the Midland community.  The generosity and benevolence of donors to the Barbara J. O’Shaughnessy Endowment Fund will provide the critical link between community and regional needs and the ability of MMH to keep abreast of the ever-changing medical needs of our community.  Although we feel the sadness of the loss of such a dear friend, we are comforted in knowing that friends and loved ones may honor Barbara’s life through memorial gifts, and ensure that her philanthropic legacy continues for generations to come.


Endowment Donors are Making the Difference

Reported by the Centers of Disease Control and Prevention, Cardiovascular disease is the Number 1 killer of women and men in the United States. Not only is this a national concern, it is a concern that affects the Midland community and surrounding areas. In 2014, through the unrestricted amount of the MMF Endowment Fund, Glendorn Equipment Fund and The B.R. Greathouse and Helen Greathouse Endowment Fund, the Foundation gifted $563,555 to Midland Memorial Hospital for the purchase of an Electrophysiology (EP) Lab that will provide state of the art equipment to effectively diagnose and treat patients with cardiac arrhythmia. The Midland Memorial Hospital Heart Institute welcomes Dr. Peter Wells who has over 20 years of experience in performing EP procedures. With the paired resources of Dr. Wells’ leadership and the ability to purchase advanced EP equipment, MMH will soon offer cardiac services that previously were outsourced to other medical facilities. Midland Memorial Foundation would like to thank the countless donors who have contributed to helping Midland Memorial Hospital provide cutting edge cardiac care right here in Midland.


EP Studies are performed to assess complex arrhythmias, prompt symptoms, evaluate abnormal electrocardiograms, assess risks of developing arrhythmias in the future, and design patient treatment.